LCN2 and coronary artery disorder: Other studies confirmed that plasma NGAL concentrations do not predict mortality independent of renal function and provide no additional benefit to inflammatory biomarkers and conventional cardiovascular risk factors in predicting cardiovascular events in stable CAD patients [20, 35].